HIV/AIDS Clinical Trials in Philadelphia

Showing 421-440 of 730 trials

Feasibility of Using a Structured Daily Diary

NCT01953653

This protocol explores the feasibility and acceptability of using two daily diary methods to analyze state-dependent variables and psychosocial health outcomes in Human Immunodeficiency Virus (HIV)-positive young men who have sex with men (YMSM). The study will explore the potential of diaries for use in feedback-based interventions.

HIV Infection

University of North Carolina, Chapel Hill67 participantsStarted Feb 2013

Aurora, Colorado, United States • Detroit, Michigan, United States • Philadelphia, Pennsylvania, United States

COMPLETED< 1 mile

Factors Affecting PrEP Adherence

NCT02411630

The purpose of this study is to test a new way to take a questionnaire that asks about adherence (whether the person is taking the medicine correctly). This new questionnaire is called Interactive Questionnaire System (iQS). In this study, the iQS will be tested on HIV-negative young men who have sex with men (YMSM) who are taking PrEP as part of another study, either ATN 110 or ATN 113.

HIV Infection

University of North Carolina, Chapel Hill167 participantsStarted Jun 2013

Los Angeles, California, United States • Aurora, Colorado, United States • Miami, Florida, United States +9 more locations

Feasibility of Using a Structured Daily Diary

Factors Affecting PrEP Adherence

HIV/AIDS Trials in Other Cities

C2P Mobilization Intervention (Pilot)

Evaluation of Genetic Markers as Explanations for the Observed Differences in Disease Progression in HIV+ Youth

Treatment De-Intensification and Residual HIV-1 in Youth

Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults

Assessing the Engagement of Transgender and Other Gender Minority Youth Across the HIV Continuum of Care

HIV Treatment-Readiness Measure (HTRM) Validation

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

A Study of HIV in Newly Infected Individuals

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients

Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected Patients

Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

ID and Testing Via Friendship Networks

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

Other Conditions in Philadelphia